New CMS TCET Rule Likely Won’t Hasten Medicare Coverage of Breakthrough Devices
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.